Search Login Register

Microangiopathic hemolytic anemia Summary

Description: merge with Schulman-Upshaw Syndrome (M0500607); split Microangiopathic hemolytic anemia

Also Known As: Thrombotic microangiopathy, familial; Upshaw factor, deficiency of; Upshaw-Schulman syndrome

Networked: 803 relevant articles (7 outcomes, 9 trials/studies) for this Bio-Agent

Key Diseases for which Microangiopathic hemolytic anemia is Relevant

  1. Thrombocytopenia (Thrombopenia) : 4 outcomes 4 studies in 486 results
  2. Neoplasms (Cancer) : 2 outcomes in 40 results
  3. Hematuria : 2 outcomes in 6 results
  4. Proteinuria : 2 outcomes in 5 results
  5. Disseminated Intravascular Coagulation : 1 outcome 1 study in 40 results
Show All >>

Drugs Related to Microangiopathic hemolytic anemia

  1. Microangiopathic hemolytic anemia
  2. Aspirin (Acetylsalicylic Acid)
  3. Dipyridamole (Persantine)
  4. Prednisone (Sone)
  5. thymidine 5'-triphosphate (TTP)
  6. Dacarbazine (DIC)
  7. Creatinine
  8. Ca(2+) Mg(2+)-ATPase
  9. Membrane Proteins (Integral Membrane Proteins)
  10. Membrane Lipids
Show All >>

Therapies Related to Microangiopathic hemolytic anemia

  1. Plasma Exchange
  2. Drug Therapy (Chemotherapy)
  3. Transplantation (Transplant Recipients)
  4. Transplants (Transplant)
  5. Renal Dialysis (Hemodialysis)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.